NL7312350A - - Google Patents
Info
- Publication number
- NL7312350A NL7312350A NL7312350A NL7312350A NL7312350A NL 7312350 A NL7312350 A NL 7312350A NL 7312350 A NL7312350 A NL 7312350A NL 7312350 A NL7312350 A NL 7312350A NL 7312350 A NL7312350 A NL 7312350A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4199272A GB1383409A (en) | 1972-09-09 | 1972-09-09 | Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7312350A true NL7312350A (nl) | 1974-03-12 |
| NL161152B NL161152B (nl) | 1979-08-15 |
| NL161152C NL161152C (nl) | 1980-01-15 |
Family
ID=10422335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7312350.A NL161152C (nl) | 1972-09-09 | 1973-09-07 | Werkwijze voor de bereiding van een preparaat met bloeddruk verlagende werking en werkwijze voor de bereiding van de daarbij te gebruiken verbindingen. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3960861A (nl) |
| JP (1) | JPS4985078A (nl) |
| AR (1) | AR203373A1 (nl) |
| AT (1) | AT330785B (nl) |
| BE (1) | BE804558A (nl) |
| CA (1) | CA995673A (nl) |
| DE (2) | DE2366106C2 (nl) |
| DK (1) | DK131725C (nl) |
| ES (1) | ES418612A1 (nl) |
| FR (1) | FR2198751B1 (nl) |
| GB (1) | GB1383409A (nl) |
| IE (1) | IE38318B1 (nl) |
| IN (2) | IN139088B (nl) |
| LU (1) | LU68373A1 (nl) |
| NL (1) | NL161152C (nl) |
| SU (1) | SU555850A3 (nl) |
| ZA (1) | ZA735660B (nl) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015018797A3 (en) * | 2013-08-05 | 2015-04-16 | Haplogen Gmbh | Antiviral compounds |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4044136A (en) * | 1972-09-09 | 1977-08-23 | Pfizer Inc. | Aminoquinazoline therapeutic agents |
| US4656174A (en) * | 1982-07-24 | 1987-04-07 | Pfizer Inc. | Quinoline therapeutic agents |
| EP0135469B1 (de) * | 1983-06-28 | 1987-06-16 | Ciba-Geigy Ag | Chromogene Chinazolinverbindungen |
| KR930702292A (ko) * | 1990-11-06 | 1993-09-08 | 알렌 제이. 스피겔 | 종양 치료 활성을 증대시키기 위한 퀴나졸린 유도체 |
| KR0144833B1 (ko) * | 1992-12-28 | 1998-07-15 | 김태훈 | 신규의 퀴나졸린 유도체 및 그의 제조방법 |
| DE4338396A1 (de) * | 1993-11-10 | 1995-05-11 | Basf Ag | N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
| IT1286302B1 (it) * | 1996-04-10 | 1998-07-08 | Rotta Research Lab | Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso |
| IN188411B (nl) | 1997-03-27 | 2002-09-21 | Yuhan Corp | |
| KR100272471B1 (ko) | 1998-11-17 | 2000-11-15 | 김선진 | 신규의 피리미딘 유도체 및 그의 제조방법 |
| US6900220B2 (en) | 2001-01-02 | 2005-05-31 | Syntex (U.S.A.) Llc | Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists |
| ATE488520T1 (de) * | 2006-08-04 | 2010-12-15 | Merz Pharma Gmbh & Co Kgaa | Pyrazolopyrimidine, ein verfahren zu ihrer herstellung und ihre verwendung als medizin |
| US8871756B2 (en) * | 2011-08-11 | 2014-10-28 | Hoffmann-La Roche Inc. | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease |
| AR099134A1 (es) * | 2014-01-24 | 2016-06-29 | Hoffmann La Roche | Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina |
| EP3298017B1 (en) | 2015-05-20 | 2019-08-14 | H. Hoffnabb-La Roche Ag | Compounds for treating spinal muscular atrophy |
| EP3322704B1 (en) | 2015-07-16 | 2019-11-27 | H. Hoffnabb-La Roche Ag | Crystalline form of n-[(3-amino-3-oxetanyl)methyl]-2-(2,3-dihydro-1,1-dioxido-1,4-benzothiazepin-4(5h)-yl)-6-methyl-4-quinazolinamine for the treatment of respiratory syncytial virus (rsv) infections |
| WO2017080967A1 (en) | 2015-11-12 | 2017-05-18 | F. Hoffmann-La Roche Ag | Compositions for treating spinal muscular atrophy |
| CN108137579B (zh) | 2015-12-10 | 2022-01-07 | 豪夫迈·罗氏有限公司 | 桥连哌啶衍生物 |
| IL281633B (en) | 2015-12-10 | 2022-07-01 | Ptc Therapeutics Inc | Methods for treating Huntington's disease |
| FR3061494B1 (fr) | 2016-12-29 | 2020-07-03 | Arkema France | Procede de synthese de dithiocarbamates cycliques fonctionnalises |
| EP3634953B1 (en) | 2017-06-05 | 2024-01-03 | PTC Therapeutics, Inc. | Compounds for treating huntington's disease |
| CA3067591A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
| US11395822B2 (en) | 2017-06-28 | 2022-07-26 | Ptc Therapeutics, Inc. | Methods for treating Huntington's disease |
| CA3094703A1 (en) | 2018-03-27 | 2019-10-03 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| WO2020005873A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heterocyclic and heteroaryl compounds for treating huntington's disease |
| US11685746B2 (en) | 2018-06-27 | 2023-06-27 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating Huntington's disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2945859A (en) * | 1960-07-19 | Diaminoquinazolines and method of | ||
| BE501634A (nl) * | 1950-03-02 | |||
| US3155572A (en) * | 1959-04-13 | 1964-11-03 | Merck & Co Inc | Compositions and methods for treating coccidiosis |
| GB1062357A (en) * | 1965-03-23 | 1967-03-22 | Pfizer & Co C | Quinazolone derivatives |
| GB1131126A (en) * | 1966-03-10 | 1968-10-23 | Pfizer Ltd | 2-vinyl-1,4-dihydroquinazoline derivatives |
| US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| US3637701A (en) * | 1969-03-03 | 1972-01-25 | Sandoz Ag | Certain nitrate derivatives of 4-aminoquinazolines |
| US3635979A (en) * | 1969-09-29 | 1972-01-18 | Pfizer | Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines |
| US3669968A (en) * | 1970-05-21 | 1972-06-13 | Pfizer | Trialkoxy quinazolines |
-
1972
- 1972-09-09 GB GB4199272A patent/GB1383409A/en not_active Expired
-
1973
- 1973-08-20 ZA ZA735660A patent/ZA735660B/xx unknown
- 1973-08-21 IN IN1920/CAL/73A patent/IN139088B/en unknown
- 1973-08-30 DK DK478273*A patent/DK131725C/da active
- 1973-08-31 CA CA180,089A patent/CA995673A/en not_active Expired
- 1973-09-03 AR AR249880A patent/AR203373A1/es active
- 1973-09-03 IE IE1560/73A patent/IE38318B1/xx unknown
- 1973-09-04 JP JP48098934A patent/JPS4985078A/ja active Pending
- 1973-09-05 US US05/394,491 patent/US3960861A/en not_active Expired - Lifetime
- 1973-09-06 DE DE2366106A patent/DE2366106C2/de not_active Expired
- 1973-09-06 AT AT774573A patent/AT330785B/de active
- 1973-09-06 BE BE135402A patent/BE804558A/xx unknown
- 1973-09-06 DE DE2345064A patent/DE2345064C3/de not_active Expired
- 1973-09-07 LU LU68373A patent/LU68373A1/xx unknown
- 1973-09-07 NL NL7312350.A patent/NL161152C/nl not_active IP Right Cessation
- 1973-09-07 FR FR7332315A patent/FR2198751B1/fr not_active Expired
- 1973-09-08 ES ES418612A patent/ES418612A1/es not_active Expired
-
1975
- 1975-01-08 SU SU2095549A patent/SU555850A3/ru active
- 1975-07-11 IN IN1357/CAL/75A patent/IN141109B/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015018797A3 (en) * | 2013-08-05 | 2015-04-16 | Haplogen Gmbh | Antiviral compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| IE38318L (en) | 1974-03-09 |
| AT330785B (de) | 1976-07-26 |
| AR203373A1 (es) | 1975-09-08 |
| ATA774573A (de) | 1975-10-15 |
| ES418612A1 (es) | 1976-07-16 |
| ZA735660B (en) | 1974-07-31 |
| GB1383409A (en) | 1974-02-12 |
| IN141109B (nl) | 1977-01-22 |
| JPS4985078A (nl) | 1974-08-15 |
| SU555850A3 (ru) | 1977-04-25 |
| IN139088B (nl) | 1976-05-08 |
| LU68373A1 (nl) | 1975-05-21 |
| DE2345064A1 (de) | 1974-04-11 |
| NL161152B (nl) | 1979-08-15 |
| FR2198751B1 (nl) | 1977-01-28 |
| NL161152C (nl) | 1980-01-15 |
| DE2345064C3 (de) | 1979-10-25 |
| DE2366106C2 (de) | 1980-02-14 |
| BE804558A (fr) | 1974-03-06 |
| CA995673A (en) | 1976-08-24 |
| AU5960673A (en) | 1975-02-27 |
| DE2345064B2 (de) | 1979-03-08 |
| DK131725C (da) | 1976-01-26 |
| DK131725B (da) | 1975-08-25 |
| IE38318B1 (en) | 1978-02-15 |
| FR2198751A1 (nl) | 1974-04-05 |
| US3960861A (en) | 1976-06-01 |
| DE2366106B1 (de) | 1979-06-21 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| V1 | Lapsed because of non-payment of the annual fee | ||
| NL80 | Information provided on patent owner name for an already discontinued patent |
Owner name: PFIZER |